Evogene

About:

Evogene is a biotechnology company developing novel products for life science markets through the use of a unique CPB platform.

Website: http://www.evogene.com

Twitter/X: evogene_ltd

Top Investors: European Union, ARK Investment Management, Alpha Capital Anstalt, Monsanto, Altium Capital

Description:

Evogene is an Ag-Biotech trait development company. The Company uses plant genomics and its technology platform to develop seed traits underlying crop performance and productivity. Evogene applies its technology through both biotechnology and breeding methods.

Total Funding Amount:

$112M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Rehovot, HaMerkaz, Israel

Founded Date:

2002-01-01

Contact Email:

info(AT)evogene.com

Founders:

Hagai Karchi, Rafael Meissner

Number of Employees:

251-500

Last Funding Date:

2024-08-23

IPO Status:

Public

Industries:

© 2025 bioDAO.ai